• Versa Biomedical draws on Specipig’s 13 years of experience as a preclinical CRO dedicated to designing flexible and personalized biomedical models. Thanks to this expertise, it will continue to offer innovative solutions to biomedical, pharmaceutical, biotechnology, and medical device companies.
• On its part, Specipig will focus on all activities related to the breeding and marketing of its own genetic line of miniature pigs, offering its services to other CROs.
• The goal of this strategic split is to enhance and reinforce the specialization of both companies, in order to provide a better service tailored to the specific needs of their clients. The differential value of Versa Biomedical + Specipig lies in the fact that they are two specialized companies in one.

A new company with 13 years of expertise 

Versa Biomedical is born with all the know-how of Specipig, a company located in Barcelona that has been in the international market for 13 years and has completed over 200 customized projects in different therapeutic areas for sponsors from 14 countries around the world.

Versa Biomedical not only conducts all types of research and preclinical studies but also offers its clients the option to advise them on the best design for their studies, specializing in 100% flexible and personalized open models.

In the words of Jaume Amat, founder and CEO of Versa Biomedical: “We are motivated to face new challenges. That’s why we help our clients define and design any type of research. To obtain the best answers, the most important thing is to formulate the right objectives and questions.”

Open models, open futures

This is the motto that defines the philosophy of the new CRO, driven by a solution-oriented mindset. Committed to innovation, Versa’s goal is to design open models to drive scientific and technological advancements. Models that serve as a platform for the verification of new and innovative health solutions and contribute to the continuous improvement of the quality of life for future users.

If something can be imagined, it can be created, just like their custom open models. Therefore, they offer a highly experienced team to develop fully customized models that meet the requirements of their sponsors. Models based on experience, rigor, and efficiency.

100% Customized Services

Versa Biomedical offers a wide variety of preclinical studies, including:

• In vivo and in vitro testing
• Proof of Concept studies
• Efficacy testing
• Toxicology and safety studies
• Pharmacology evaluations
• Pharmacokinetic and pharmacodynamic studies
• Medical device testing from prototype to regulatory phase
• Biocompatibility studies (ISO 10993 local and systemic) and safety

A solid and prestigious network of collaborators

Versa Biomedical has a network of collaborators formed by a large and growing team of expert surgeons in human medicine who, in collaboration with our veterinary team, provide the best services for the design and development of new solutions for human health.

All of them contribute to ensuring that Versa’s preclinical developments meet their sponsors’ objectives regarding safety and efficacy. This collaboration with experts in a wide range of medical disciplines will allow the new company to continue expanding its therapeutic areas of specialization with each new project.

Versa + Specipig: an added value

The differential value of Versa Biomedical + Specipig lies in the fact that they are two specialized companies in one: they breed their own animal breed and offer innovative research services in fully equipped facilities, open to companies and institutions around the world.